MSB 3.33% $1.09 mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-707

  1. 3,812 Posts.
    lightbulb Created with Sketch. 359
    I agree with you here. For memory Dr Grossman did say early on things were going to plan. But, common sense here, we know it's a complex trial and regardless the spike in cases. Rem_l is for patients on ventilators and the difficult part is convincing them to participate on trial.

    investors can argue the company needs to inform shareholders of current situation.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
-0.038(3.33%)
Mkt cap ! $1.255B
Open High Low Value Volume
$1.14 $1.16 $1.08 $5.610M 5.063M

Buyers (Bids)

No. Vol. Price($)
6 59342 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.09 96264 22
View Market Depth
Last trade - 14.27pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.